Clinical trial · Observational
Familial B-cell Lymphoproliferative Disorders
Epidemiology of Familial B-cell Lymphoproliferative Disorders
NCT05718986CI-TRIAL-00076934Familial_LPDnot yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study investigates families with at least two cases of B-cell lymphoproliferative disorders (LPD), and evaluates the prevalence of LPD in families, the relationship between medical history, genetic factors, and the risk of familial LPD, and various clinical outcomes for these families in a multiethnic population of Jews and Arabs in Israel.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Lymphocytic Leukemia | Chronic Lymphocytic Leukemia | ONTOLOGY_EXACT | 0.98 |
| Lymphoproliferative Disorders | — | UNRESOLVED | — |
| Monoclonal B-Cell Lymphocytosis | Monoclonal B-Cell Lymphocytosis | ONTOLOGY_EXACT | 0.98 |
| Premalignant | Premalignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (15)
- label
- Bnai Zion Medical Center
- description
- Bnai Zion Medical Center
- interventionNames
- Other: No intervention
- label
- Tel Aviv Sourasky Medical Center - Ichilov Hospital
- description
- Tel Aviv Sourasky Medical Center - Ichilov Hospital
- interventionNames
- Other: No intervention
- label
- Galil Medical Center
- description
- Galil Medical Center
- interventionNames
- Other: No intervention
- label
- Ziv Medical Center
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient inclusion criteria: Patients must have LPD and must have a family history of LPD. LPD patients who signed an informed consent to participate in the study. Criteria for the inclusion of relatives of patients: Relatives must be related by blood to LPD patients or unrelated (for control group). Relatives who signed an informed consent to participate in the study. Exclusion Criteria: * Pregnant women, special populations and those lacking judgment will not be included
References
Publications (0)
Data not yet available
No reference posted for this study.